RAC 1.11% $1.83 race oncology ltd

I had originally thought the trial design clever in EMD AML with...

  1. 125 Posts.
    lightbulb Created with Sketch. 33
    I had originally thought the trial design clever in EMD AML with RC110 as it potentially offered an opportunity to gather data on FTO and Cardio Protection (and not dependent on readiness of RC220) in clinic for an unmet need in a subgroup (and thereby overcoming the crowded trial space issue). I
    This also meant access to less heavily pretreated patients possibly offering better/clearer data (attribution). Do you see issue in focusing on r/r AML patient group (data and clinical development)?
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.83
Change
0.020(1.11%)
Mkt cap ! $310.8M
Open High Low Value Volume
$1.81 $1.83 $1.79 $142.0K 78.77K

Buyers (Bids)

No. Vol. Price($)
1 500 $1.81
 

Sellers (Offers)

Price($) Vol. No.
$1.83 641 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.